Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(4 sites)
United States
VA Greater Los Angeles Healthcare System,Cancer Center Research, Los Angeles, California University of Maryland, Baltimore, Maryland Chesapeake Urology Research Associates, Towson, Maryland Pennsylvania Cancer Specialists & Research Institute (Formerly Gettysburg Cancer Center), Gettysburg, Pennsylvania